Synonyms:
Status: Phase 1
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: YO3O4Q2NC8

Structure

InChI Key ICYNYWFGIDGBRD-UHFFFAOYSA-N
Smile COc1ccc(Cl)cc1-c1cc(=O)[nH]c(=S)n1CC(N)=O
InChI
InChI=1S/C13H12ClN3O3S/c1-20-10-3-2-7(14)4-8(10)9-5-12(19)16-13(21)17(9)6-11(15)18/h2-5H,6H2,1H3,(H2,15,18)(H,16,19,21)

Physicochemical Descriptors

Property Name Value
Molecular Formula C13H12ClN3O3S
Molecular Weight 325.78
AlogP 1.72
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 4.0
Polar Surface Area 90.11
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 21.0

Pharmacology

Primary Target
myeloperoxidase
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Oxidoreductase
- 1900 - 316 -

Indications

Mesh Heading Maximum Phase Reference
Overweight Phase 1 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1435467-37-0
ChEMBL CHEMBL3633460
DrugBank DB11683
FDA SRS YO3O4Q2NC8
Guide to Pharmacology 10053
PubChem 71571306
SureChEMBL SCHEMBL14936135
ZINC ZINC000205775084